Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-028883
Filing Date
2024-12-10
Accepted
2024-12-10 18:31:19
Documents
2
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 form3-12102024_111214.html 3  
1 form3-12102024_111214.xml 3 1716
2 ex24-12102024_111216.htm EX-24 3353
  Complete submission text file 0001415889-24-028883.txt   6519
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2445 TECHNOLOGY FOREST BLVD 11TH FLOOR SPRING TX 77381
Business Address
Garner Thomas (Reporting) CIK: 0001996325 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 241539667